Contrast Media & Molecular Imaging / 2019 / Article / Fig 3

Research Article

99mTc-Labeled LyP-1 for SPECT Imaging of Triple Negative Breast Cancer

Figure 3

Cellular uptake of LyP-1-FITC and ARAL-FITC by 4T1 cells was examined by flow cytometry. Cells were treated with the drug-free medium (a), ARAL-FITC (b), or LyP-1-FITC (c) at a concentration of 10 μM for 2 h, and the statistical analysis results are shown in (d). Cells treated with 10 μM ARAL-FITC (e) and LyP-1-FITC (f) were analyzed after incubation for 3 h, and the difference was compared in (g). The relative fluorescence signals of cells treated with ARAL-FITC (h) or LyP-1-FITC (i) were compared for 2-3 h incubation, respectively.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.